Deirdre Costello

Deirdre Costello is an accomplished professional in structural biology, currently serving as the Associate Director at Genesis Therapeutics since March 2025. Prior experience includes the role of Principal Scientist at Treeline Biosciences and multiple positions at Eli Lilly and Company, where Deirdre advanced from Research Scientist to Senior Research Scientist. Academic credentials include a PhD and MS in Chemical and Biomolecular Engineering from Cornell University, complemented by a BS in Chemical Engineering from University College Dublin. Deirdre's doctoral research focused on the fusion kinetics of influenza, contributing to the development of anti-fusogenic therapeutics. Additional experience includes a postdoctoral position at Harvard Medical School and instructional roles fostering engineering education for youth.